Merck To Pay Up To $425m For Foghorn’s Gene Regulation Therapies
Major Deal For ‘Gene Traffic Control’ Company
US major continues its expansion in oncology with an early stage deal with Flagship Pioneering protegés.
US major continues its expansion in oncology with an early stage deal with Flagship Pioneering protegés.